It felt like déjà vu at media day for the Colorado Avalanche.
A year ago, the most pressing questions for the Avs’ top players and coach Jared Bednar were about Valeri Nichushkin, after he left the team during its first-round playoff exit against the Seattle Kraken.
Nichushkin isn’t alone among the key forwards who aren’t available at the start of this training camp, but he was yet again the key talking point Wednesday while he remains suspended from the team through at least mid-November.
Extended infusion of beta-lactam therapy was associated with reduced mortality in patients with severe gram-negative bloodstream infections, according to a retrospective cohort study. At 90
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology in preparation for customer use and commercialization.
Howard Meyers, of Dallas, Texas, a member of The University of Texas MD Anderson Cancer Center Board of Visitors (BOV), has committed $25 million to